Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study
Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study
Not yet recruiting · NCT07509112 · Registry updated 2026-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study | Chemically-Induced Disorders, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 2 | 2026-06-26 | NCT07509112 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kirby Institute | 19 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alcohol & Drug Service, Metro Health North Brisbane | Brisbane | Australia | 1 |
| Drug and Alcohol Services, South Australia | Morphett Vale | Australia | 1 |
| Kirketon Road Centre | Darlinghurst | Australia | 1 |
| Next Step Drug and Alcohol Services | East Perth | Australia | 1 |
| Rankin Court Treatment Centre, St Vincent's Hospital Sydney | Darlinghurst | Australia | 1 |